HomeTLSI • NASDAQ
TriSalus Life Sciences Inc
add
Market news
NDAQ
0.65%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 9.17M | 41.97% |
Operating expense | 15.00M | -12.57% |
Net income | -10.38M | 21.44% |
Net profit margin | -113.18 | 44.66% |
Earnings per share | -0.27 | 55.83% |
EBITDA | -7.16M | 37.75% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.00M | 227.46% |
Total assets | 28.63M | 60.01% |
Total liabilities | 63.00M | 19.28% |
Total equity | -34.37M | — |
Shares outstanding | 37.84M | — |
Price to book | -4.90 | — |
Return on assets | -69.67% | — |
Return on capital | 1,041.35% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -10.38M | 21.44% |
Cash from operations | -4.50M | 58.60% |
Cash from investing | -714.00K | -981.82% |
Cash from financing | 9.69M | 209.92% |
Net change in cash | 4.48M | 157.32% |
Free cash flow | -2.39M | 63.44% |
Previous close
$5.19
Day range
$5.18 - $5.42
Year range
$3.50 - $6.08
Market cap
203.20M USD
Avg Volume
39.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Headquarters
Website
Employees
110